-+ 0.00%
-+ 0.00%
-+ 0.00%

AGENUS REPORTS 72% OF PATIENTS WITH LOCALLY ADVANCED DMMR COLON CANCER HAD NO CANCER REMAINING AT SURGERY FOLLOWING SIX WEEKS OF BOT+BAL IN PHASE 2 NEOASIS STUDY AT ESMO 2026

Reuters·10/25/2026 11:00:00

Please log in to view news